Know Labs Announces $300K Registered Direct Offering; This Was A Unit Offering Comprised Of 1 Share Of Stock And 1 Warrant, The Purchase Price Of The Unit Was $0.24 A Share And The Warrant Is Exercisable At $0.24
Know Labs Announces $300K Registered Direct Offering; This Was A Unit Offering Comprised Of 1 Share Of Stock And 1 Warrant, The Purchase Price Of The Unit Was $0.24 A Share And The Warrant Is Exercisable At $0.24
Know Labs, Inc. (NYSE:KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a registered direct offering with gross proceeds to the company of $300K before deducting placement agent fees and other estimated expenses payable by the Company.
領先的非侵入性醫療診斷技術開發商Know Labs, Inc.（紐約證券交易所代碼：KNW）（「公司」）今天宣佈了註冊直接發行的定價，該公司的總收益爲30萬美元，扣除配售代理費和公司應付的其他估計費用。
This was a unit offering comprised of one share of stock and one warrant. The purchase price of the unit was $0.24 a share and the warrant is exercisable at $0.24. The warrants will expire on the fifth anniversary of the warrant issuance. The warrants also have a cashless exercise option in certain circumstances. This was a registered direct offering priced at-the-market under NYSE American rules.
這是一次由一股股票和一份認股權證組成的單位發行。該單位的收購價格爲每股0.24美元，認股權證可行使價格爲0.24美元。認股權證將在認股權證發行五週年之際到期。在某些情況下，認股權證還有無現金行使選項。這是根據紐約證券交易所美國規則在市場上定價的註冊直接發行。
